Black Deal 12 months of Premium for €49.99 instead of €74.99 12 months €49.99 instead of €74.99 until Sun, Dec 13
Get the deal

B1izzard- - FACEIT level 9, 1,864 ELO

San Marino
On FACEIT since 2023 195 matches tracked 10 matches in 30 days
Last updated:

B1izzard- at a glance

Level 9 1,864 ELO best map Nuke (70%)
Level 9

Last 20 matches compared with 2,995 players in this group: K/R, ADR and win rate below average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 9%
0.86
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.25 ConsistencyShare of matches with a rating of 0.90 or higher. 45%
K/R
0.62
better than 9% of players
Level 9 avg: 0.73
Last 12 months
ADR
73.3
better than 20% of players
Level 9 avg: 79.8
Last 12 months
Win rate
45%
better than 32% of players
Level 9 avg: 50%
Last 12 months

Facts

137 ELO Next goal That is 3 to 5 wins.
2 W · 1 L Best day +13 ELO · Sep 22, 2026
3 W · 2 L Overtime in overtime
Ancient Favorite map 46 of 195 matches
Nuke 70% Map pool tip weakest: Cache 21%
19:00-22:00 Playing times On Saturdays
On Fridays Best time 72% win rate vs. 51%
FormMapsTiming

137 ELO away from level 10. That is 3 to 5 wins. 2:1 on Sep 22, 2026 (+13 ELO, last 90 days). 5 matches in overtime, 3 of them won (last 90 days). Most played: Ancient (46 of 195 matches). Strongest map: Nuke (70% win rate, 46 matches). Weakest: Cache (21%, 14 matches). Plays most on Saturdays between 19:00 and 22:00 (based on 195 matches). Best results on Fridays: 72% win rate vs. 51% overall (29 matches).

About B1izzard-

B1izzard- plays CS2 on FACEIT level 9 with 1,864 ELO. The stats cover 195 matches. The strongest map is Nuke with a 70% win rate in 46 matches. Most played: Ancient with 46 matches and a 61% win rate. Biggest strength: Utility damage per round at 8.6, better than 99% of level 9 players. Last 20 matches: 9 wins, 11 losses, -123 ELO. B1izzard- does best on Fridays: 72% win rate in 29 matches.